Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
U.S., China key to GSK's consumer venture with Pfizer
Yahoo/Reuters
Thu, 04/4/19 - 12:06 pm
China
GSK
Pfizer
consumer healthcare
Teva, Pfizer Seek Clarity on Tentative ANDA Approval Draft Guidance
RAPS.org
Tue, 04/2/19 - 11:31 pm
Pfizer
Teva Pharmaceutical
FDA
complete response letter
Sangamo Stock Soars on Positive Hemophilia Treatment Trial
TheStreet.com
Tue, 04/2/19 - 11:59 am
Sangamo BioSciences
Pfizer
SB-525
hemophilia
clinical trials
Pfizer biotech spinout nabs $125M megaround as Bain-backed syndicate bets on its late-stage game plan
Endpoints
Mon, 04/1/19 - 12:35 pm
Pfizer
SpringWorks Therapeutics
nirogacestat
PD-0325901
Pfizer squeezes out positive data for fructose-fighting NASH drug
Biopharma Dive
Fri, 03/29/19 - 10:16 am
Pfizer
NASH
clinical trials
EMA sounds its own safety alarm for Pfizer blockbuster, but they’re also not forcing a limit on dosing — yet
Endpoints
Wed, 03/20/19 - 08:14 pm
Pfizer
Xeljanz
Europe
EMA
rheumatoid arthritis
Pfizer buys stake in French gene therapy firm Vivet
CNBC
Wed, 03/20/19 - 09:57 am
Pfizer
M&A
Vivet
gene therapy
liver disease
Pfizer, Merck KGaA throw in the towel on another Bavencio PhIII as once bright hopes shrivel fast
Endpoints
Tue, 03/19/19 - 08:22 pm
Pfizer
Merck KGaA
ovarian cancer
Bavencio
R&D round-up: Non-opioid painkiller space heats up
Pharmaforum
Sat, 03/16/19 - 12:38 pm
painkillers
opioids
non-opioid pain treatments
Merck
Kings College London
Pfizer
Eli Lilly
tanezumab
Xeljanz
Using Pfizer’s smoking-cessation treatment Chantix to control neurons for drug research
Fierce Biotech
Thu, 03/14/19 - 11:16 pm
Pfizer
Chantix
Ian Read bags $19.5 million, taking a big pay cut for his swan song as Pfizer CEO and leaving the pharma giant at a crossroads
Endpoints
Thu, 03/14/19 - 11:13 pm
Pfizer
Pharma CEOs
executive pay
Ian Read
Albert Bourla
Pfizer gets FDA approval for oncology biosimilar Trazimera
Pharmaceutical Business Review
Tue, 03/12/19 - 11:33 am
Pfizer
FDA
Trazimera
Genentech
biosimilars
Herceptin
Pfizer settles Oregon probe over false advertising
Seattle Times, WA
Mon, 03/11/19 - 10:05 pm
Pfizer
Oregon
copay coupons
AbbVie and Pfizer return to the top of pharma's TV spending list for February
Fierce Pharma
Wed, 03/6/19 - 11:36 am
AbbVie
Humira
Pfizer
Xeljanz
television ads
DTC ads
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Tue, 03/5/19 - 10:02 am
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Top 10 drugs losing exclusivity in 2019
Fierce Pharma
Tue, 03/5/19 - 09:40 am
market exclusivity
patents
Rituxan
Lyrica
Herceptin
Avastin
Epclusa
Harvoni
Pfizer
Roche
Gilead Sciences
Amgen
GSK
Allergan
Individor
Teva launches generic for Pfizer’s Flector pain patch
Drug Delivery Business News
Mon, 03/4/19 - 07:31 pm
Teva Pharmaceutical
generics
Pfizer
Flector
pain patches
AbbVie, Akcea benefit from latest CHMP recommendations
Biopharma Dive
Sun, 03/3/19 - 07:12 pm
Europe
CHMP
AbbVie
Akcea
Biomarin
Sanofi
Pfizer
drug approvals
Pfizer’s blockbuster safety issue jumps the Atlantic as EMA launches its own review of Xeljanz
Endpoints
Fri, 03/1/19 - 12:07 pm
Pfizer
Europe
JAK inhibitors
Xeljanz
Pfizer unit Meridian under civil investigation by U.S. Attorney
Yahoo/Reuters
Fri, 03/1/19 - 09:31 am
Pfizer
Meridian Medical Technologies
drug manufacturing
Epi Pens
Pages
« first
‹ previous
…
86
87
88
89
90
91
92
93
94
…
next ›
last »